Education
About Us
Working with TipRanks
Follow Us
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
Earnings Data
Report Date
Feb 19, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.75Last Year’s EPS
-1.4Same Quarter Last Year
Strong Buy
Based on 19 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call showcased positive developments with successful Phase III trial results and strong financial performance. However, challenges such as market access competition and increased operating expenses were noted.Company Guidance
Successful Phase III Trials
Announced two successful Phase III trials: FORTIFY trial of BBP-418 in limb-girdle muscular dystrophy type 2i and CALIBRATE trial of encaleret in autosomal dominant hypocalcemia type 1, both exceeding expectations.
Attruby's Market Performance
Delivered 5,259 unique patient prescriptions to 1,355 unique healthcare providers, generating $108.1 million in net product sales this quarter, with a goal of achieving a 30-35% market share.
Expansion and Growth Strategy
Continued expansion efforts with Beyonttra in Europe and plans to leverage real-world evidence studies. Preparing for potential new launches in the pipeline, including encaleret, BBP-418, and infigratinib.
Strong Financial Position
Reported $120.7 million in total revenues for Q3 2025 and ended the quarter with $645.9 million in cash, cash equivalents, and marketable securities.
BBIO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BBIO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 29, 2025 | $66.62 | $63.37 | -4.88% |
Aug 05, 2025 | $49.21 | $44.81 | -8.94% |
Apr 29, 2025 | $36.42 | $38.36 | +5.33% |
Feb 20, 2025 | $36.29 | $36.80 | +1.41% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BridgeBio Pharma Inc (BBIO) report earnings?
BridgeBio Pharma Inc (BBIO) is schdueled to report earning on Feb 19, 2026, After Close (Confirmed).
What is BridgeBio Pharma Inc (BBIO) earnings time?
BridgeBio Pharma Inc (BBIO) earnings time is at Feb 19, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BBIO EPS forecast?
BBIO EPS forecast for the fiscal quarter 2025 (Q4) is -0.75.